Investment catalyzes Tute Genomics’ efforts to enable genome-guided, individualized medicine in everyday healthcare. FOR IMMEDIATE RELEASE PROVO, Utah, June 16, 2015 – Tute Genomics, a leader in cloud-based analytics, interpretation, and reporting for clinical sequencing, today announced the closing of its Series A1 round of venture capital funding. The company raised over $3.9 million from … Continue reading Tute Genomics Closes Additional Series A1 Funding With Strategic Investment From Intermountain Healthcare, Healthbox, and Tencent
Author: Reid Robison
PRESS RELEASE: Tute Genomics raises $2.3 million to scale up cloud-based genome analytics and accelerate personalized medicine
Unprecedented genetic variant database to power the world’s genomic knowledge, bring DNA sequencing into everyday healthcare Provo, Utah, December 4, 2014 — Tute Genomics, a leader in cloud-based solutions for genome analysis, has raised $2.3 million in Series A1 funding led by UK-based Eurovestech. Peak Ventures and a number of angel investors also participated in … Continue reading PRESS RELEASE: Tute Genomics raises $2.3 million to scale up cloud-based genome analytics and accelerate personalized medicine
PRESS RELEASE: Tute Genomics Launches MyGene Portal for Genome-guided Medicine, Selected to Showcase Healthcare Innovation at TEDMED The Hive
Tute Genomics Launches MyGene Portal for Genome-guided Medicine Selected to Showcase Healthcare Innovation at TEDMED The Hive Washington, DC // Today at the TEDMED conference, Tute Genomics announced the launch of MyGene, a patient portal that puts genome sequencing results at the fingertips of the individual where it is most useful and actionable. The $1000 … Continue reading PRESS RELEASE: Tute Genomics Launches MyGene Portal for Genome-guided Medicine, Selected to Showcase Healthcare Innovation at TEDMED The Hive